Adam Geyer, M.D.
NPI 1508804238 · Dermatology Physician · New York, NY
Enrolled with Medicare as Practitioner - Dermatology · source: CMS PECOS Public Provider Enrollment (2026.04.01)
Adam Geyer, M.D. is a Dermatology Physician provider in New York, NY (NPI 1508804238).
Provider details
- NPI number
- 1508804238
- Entity type
- Individual
- Primary specialty
- Dermatology PhysicianAllopathic & Osteopathic Physicians
- Credential
- M.D.
- Sex
- Male
- Sole proprietor
- Yes
- License
- 223986 (NY)
Specialties & taxonomies
Allopathic & Osteopathic Physicians
Profile Score
A profile completeness & documented-activity index — NOT a quality, outcomes, or patient-satisfaction rating.
- Registry tenure25% of score
20 yrs in NPPES registry
- Profile completeness25% of score
100% of core fields populated
- Practice footprint15% of score
1 documented practice location
- Medicare service volume (vs. specialty peers)25% of score
43,428 Medicare services, 2024 (ranked within specialty)
- Open Payments transparency10% of score
Has Open Payments disclosures (2024)
Medicare volume is ranked against active providers in the same specialty. Signals a provider has no public data for (e.g. Medicare claims) are left out of the score entirely — never counted as zero — so providers without that data are not penalized. See the full formula and weights in our .
What this provider does (Medicare)
Based on Medicare fee-for-service claims, 2024; not all care is captured.
| Service (HCPCS) | Medicare services | Typical Medicare-allowed (2024) |
|---|---|---|
| Injection, Sculptra, 0.5 MgQ2028 | 41,160 | $0 |
| Destruction of Precancer Skin Growth, 2-14 Growths17003 | 783 | $7 |
| Established Patient Office Or Other Outpatient Visit With Low Level OD Decision Making, If Using Time, 20 Minutes Or More99213 | 500 | $101 |
| Destruction of Precancer Skin Growth, 1 Growth17000 | 311 | $59 |
| Destruction of Skin Growth, 1-14 Growths17110 | 154 | $127 |
| Biopsy of Related Skin Growth, First Growth11102 |
What this provider prescribes (Medicare Part D)
Top drugs by Medicare Part D claim volume, 2024 · 16 distinct drugs on file.
| Drug | Part D claims (2024) | Beneficiaries |
|---|---|---|
| Triamcinolone Acetonide | 71 | 56 |
| Ciclopirox Olaminebrand: Ciclopirox | 67 | 46 |
| Minoxidil | 59 | 22 |
| Clindamycin Phosphate | 45 | 16 |
| Clobetasol Propionate | 41 | 23 |
| Ketoconazole | 40 | 21 |
| Doxycycline Hyclate | 30 | 15 |
| Fluorouracil | 30 |
Transparency — industry payments
Based on CMS Open Payments, 2024; not all care is captured.
$1,375 across 74 records (Open Payments 2024)
Open Payments discloses payments and transfers of value (meals, travel, consulting, research, royalties) from drug and device makers to providers. This is a transparency signal, not a verdict — such payments are legal and common, and their presence is neither an endorsement nor a criticism. Source: CMS Open Payments, program year 2024.
Practice location
Mailing address
Registry dates
- Enumerated
- 2006-06-03
- Last updated
- 2013-11-27
Frequently asked questions
- What is Adam Geyer's NPI number?
- Adam Geyer's National Provider Identifier (NPI) is 1508804238, a unique 10-digit ID issued by CMS for use in standard healthcare transactions.
- What is Adam Geyer's specialty?
- Adam Geyer is listed in the NPPES registry with a primary specialty of Dermatology Physician (Allopathic & Osteopathic Physicians).
- Where is Adam Geyer located?
- Adam Geyer's practice location on file with NPPES is 30-32 Ericsson Place, New York, NY 10013-6301.
- What is Adam Geyer's phone number?
- The practice phone number listed in the NPPES registry for Adam Geyer is (212) 374-9750.
- Does Adam Geyer accept Medicare?
- Adam Geyer is approved to bill Medicare according to CMS PECOS enrollment data (2026.04.01). Confirm current participation with the provider before scheduling.
- Is Adam Geyer's NPI active?
- Yes — Adam Geyer's NPI (1508804238) is active in the NPPES registry as of the last update on 2013-11-27.
Source: CMS NPPES Data Dissemination (June 2026). NPI Central is not affiliated with CMS. Data is provided as-is from the public registry.